Foghorn Therapeutics FHTX Cash Flow Statement (2019-2026)

NASDAQ FHTX
$4.91 +0.05 (+0.92%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Foghorn Therapeutics Quarterly Cash Flow Statement

Periods 28 quarters
Latest Jun 2026

Foghorn Therapeutics reported cash from operations of -$17.84M and free cash flow of -$17.86M for the quarter ended Jun 2026, up 15.0% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-26.76M-28.51M-26.91M-27.31M-25.77M-28.89M-30.49M-29.49M-14.35M-24.11M-25.02M-22.98M-19.12M-19.50M-20.22M-18.79M-16.47M-22.17M-19.83M-7.20M
Share-based CompensationStock Comp.
2.37M2.08M3.24M3.51M3.80M3.78M4.57M4.47M4.09M3.05M3.22M3.17M3.02M2.48M2.69M2.73M2.73M2.24M2.38M2.55M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
2.40M0.00M5.91M
Cash from OperationsCash from Ops.
-20.50M11.88M271.53M-29.01M-19.99M-28.92M-31.18M-32.17M-27.21M-27.54M-29.34M-25.54M-21.00M-24.52M-23.97M-21.00M-18.86M-22.27M-25.27M-17.84M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-0.10M-0.10M-0.04M0.33M0.43M0.57M0.77M0.73M0.66M0.49M0.55M0.70M1.78M1.57M0.82M0.45M0.36M0.31M0.39M0.62M
Depreciation & Amortization (CF)Dep. & Amort.
0.80M0.81M0.81M0.80M0.90M0.82M0.90M0.80M0.90M0.90M0.83M0.80M0.70M0.72M0.83M0.90M0.90M0.80M0.24M0.20M
Change in Working Capital
Change in Account PayablesChange Payables
0.41M-0.02M1.27M-1.44M1.62M0.16M1.69M-0.17M-0.44M-0.24M-0.63M-0.83M-1.35M0.33M0.28M-0.75M-0.11M1.05M-0.99M-0.07M
Change in Accured ExpensesChange Accured Exp.
1.95M2.40M-2.54M1.09M2.00M0.89M-2.15M-0.67M0.69M0.33M-2.81M-0.30M4.97M-2.42M-2.41M2.02M1.16M1.44M-4.46M1.06M
Other Working Capital ChangesOther WC Changes
-0.04M337.08M-3.92M-4.49M-1.63M-4.18M-5.31M-5.60M-17.48M-5.77M-5.05M-6.89M-7.81M-2.86M-5.95M-7.56M-8.15M-9.25M-3.27M-16.07M
Investing Activities
Capital ExpendituresCapex
0.23M0.08M0.25M0.36M0.33M0.27M0.64M0.47M0.08M0.04M0.10M0.02M0.31M0.48M0.03M0.02M0.04M0.01M
Change in Acquisitions & DivestmentsChange Acquisitions
20.00M53.13M19.00M56.00M38.10M56.37M76.57M42.37M44.26M58.46M48.15M63.45M62.42M80.55M76.00M39.58M47.21M49.22M34.17M
Cash from Investing ActivitiesCash from Investing
-47.33M9.67M-159.41M-124.46M46.05M-6.51M29.50M39.13M38.43M37.38M27.09M-17.98M-61.31M22.29M29.40M33.83M35.57M13.23M-17.72M-2.97M
Financing Activities
Other financing activitiesOther financing
0.51M41.53M0.38M1.03M0.33M0.02M0.10M0.10M1.39M0.19M1.17M1.44M0.00M0.14M0.25M0.05M0.04M0.09M0.01M
Cash from Financing ActivitiesCash from Financing
0.51M21.74M0.38M1.03M0.33M0.02M0.10M0.10M1.39M0.19M1.17M103.21M1.05M0.00M0.14M0.25M0.05M0.58M49.77M-0.02M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
0.54M50.00M
Additional items
Change in Cash
-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M-8.46M6.79M-20.83M
Free Cash FlowFCF
-20.73M11.80M271.29M-29.38M-20.32M-29.19M-31.82M-32.64M-27.29M-27.58M-29.45M-25.55M-21.31M-25.00M-24.00M-21.02M-18.86M-22.27M-25.30M-17.86M
Net Cash FlowNCF
-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M-8.46M6.79M-20.83M